Mitotech, SA
Quick facts
Phase 3 pipeline
- High dose - SkQ1 · Ophthalmology; Age-related degenerative diseases
SkQ1 is a mitochondrial-targeted antioxidant that accumulates in mitochondria to neutralize reactive oxygen species and protect against oxidative damage. - Low Dose - SkQ1 · Ophthalmology; Age-related degenerative diseases
SkQ1 is a mitochondria-targeted antioxidant that accumulates in mitochondria to neutralize reactive oxygen species and protect against oxidative damage. - SkQ1 Ophthalmic Solution · Ophthalmology
SkQ1 Ophthalmic Solution is a mitochondrially-targeted antioxidant that aims to protect retinal cells from oxidative stress. - SkQ1 Vehicle Solution · Ophthalmology, Cardiology
SkQ1 is a mitochondrially-targeted antioxidant that aims to delay the onset of age-related diseases.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: